abstract |
The present invention relates to novel compounds of formula (I), pharmaceutical preparations containing the compounds, and the use of such compounds in the prophylaxis and / or treatment of mGluR 5 receptor-mediated diseases.n n n <Formula I>n n n n n n n n Heteropolycyclic compounds, metabolic glutamate receptors, neurotransmitters |